Back
Milestone Pharmaceuticals Vs. Nebius Group NV Industry Stock Comparison
Sell
46
MIST
Milestone Pharmaceuticals
Last Price:
$1.97
Seasonality Move:
-17.08%
Sell
41
NBIS
Nebius Group NV
Last Price:
$28.04
Seasonality Move:
-4.07%
Sell
46
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals [MIST] share price is $1.85. The Score for MIST is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $28.25. The Score for NBIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $28.25The current trend is moderately bearish and NBIS is experiencing slight buying pressure.
MIST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 54.63 | Buy |
Chaikin Money Flow: | 77693 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.77 - 1.91) | Buy |
Bollinger Bands (100): | (1.4 - 1.78) | Buy |
NBIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.41 | Buy |
Relative Strength Index (14 RSI): | 52.29 | Buy |
Chaikin Money Flow: | 299015 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.06 - 32.3) | Buy |
Bollinger Bands (100): | (16.89 - 25.75) | Buy |
MIST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.79 | Buy |
20-day SMA: | 1.85 | Buy |
50-day SMA: | 1.72 | Buy |
200-day SMA: | 1.58 | Buy |
8-day EMA: | 1.81 | Buy |
20-day EMA: | 1.81 | Buy |
50-day EMA: | 1.74 | Buy |
200-day EMA: | 1.75 | Buy |
NBIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.9 | Sell |
20-day SMA: | 29.09 | Sell |
50-day SMA: | 23.69 | Buy |
200-day SMA: | 20.13 | Buy |
8-day EMA: | 28.69 | Sell |
20-day EMA: | 28.11 | Buy |
50-day EMA: | 25.05 | Buy |
200-day EMA: | 21.08 | Buy |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.20 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Milestone Pharmaceuticals Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nebius Group NV Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |